- People meeting clinical criteria based on cancer, cardiac or family history
- Families with a known pathogenic variant
- People prepared for medical and family implications
TEST PASSPORT · REVIEWED JULY 2026
Hereditary cancer + cardiac gene panels
Use medical-grade genetics when personal or family history makes the result actionable.Targeted panels can identify inherited variants that alter surveillance or family testing. Pre- and post-test counseling matter because uncertain and incidental findings are common.

HOW TO USE THIS PAGE
Decide whether this test deserves a place in your plan.
- 01Confirm the question
Be clear about what decision the result would change before ordering.
- 02Check fit and preparation
Review who it helps, who should pause and how to protect the quality of the signal.
- 03Plan the response
Know what you will do with a normal, abnormal or unclear result.
01 / WHO SHOULD TAKE IT
Fit the test to
the person.
Testing is useful when the result can change a real decision. These are educational selection criteria, not a diagnosis or personal order.- Assuming a negative consumer panel eliminates inherited risk
- Ordering broad panels without a plan for uncertain variants
02 / SIGNAL VS. STORY
What it tells you.
What it cannot.
Pathogenic/likely pathogenic variants in tested genes
Whether targeted family testing may be useful
Potential changes to surveillance when supported by guidelines
Not every risk gene or variant is known or tested
A variant of uncertain significance is not a positive diagnosis
Privacy, insurance and family implications deserve discussion
03 / MARKERS + RANGES
Read the panel
without chasing flags.
The report should show its own method, units and laboratory reference interval. Clinical decision thresholds may be different from a lab interval. We do not invent a universal “optimal” range where authoritative guidance does not support one.Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
The correct range is personal context—not pink versus blue numbers.
Where biology differs, we call it out. Clinical interpretation should also reflect organs present, hormone therapy, pregnancy, age, medications and health history.
Ovary, breast and uterine history may change panel criteria and surveillance; genes can be inherited from either parent.
Male breast, prostate, pancreatic and cardiac history can be highly informative; genes can be passed to all children.
04 / PREPARATION
Protect the quality
of the signal.
The best assay cannot rescue the wrong timing, wrong specimen or wrong question. Follow the ordering clinician and laboratory instructions when they differ from this general guide.Collect cancer/cardiac diagnoses and ages from both sides of the family.
Clarify what positive, negative and uncertain results could change.
Read data retention, research use and deletion policies before consenting.
05 / AFTER THE RESULT
Turn the number
into a next step.
- 01
Confirm medical action through a genetics professional
- 02
Offer cascade testing to relatives when appropriate
- 03
Keep the original laboratory report for future reinterpretation
Do not delay evaluation of a suspicious symptom while waiting for genetics
Major distress or family conflict deserves counseling support
06 / MODERN BIO SELECT
Built for a responsible purchase path.
Any future sale must include consent, privacy clarity, counseling and confirmatory care.Hereditary cancer + cardiac gene panels
- Future format
- Eligibility screen + genetic counseling + medical-grade panel
- Price position
- Panel-specific transparent price
- Before checkout
- Eligibility · method · privacy · total cost · interpretation · abnormal-result routing
07 / SCIENTIFIC FOUNDATION